Inovio Pharmaceuticals
INO
#8985
Rank
NZ$0.20 B
Marketcap
NZ$2.95
Share price
3.57%
Change (1 day)
-13.67%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.88. In 2024 the company made an earnings per share (EPS) of NZ-$6.69 an increase over its 2023 EPS that were of NZ-$10.32.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-28.21%
2024NZ-$6.69-35.14%
2023NZ-$10.32-56.62%
2022NZ-$23.79-19.54%
2021NZ-$29.5735.9%
2020NZ-$21.75-11.57%
2019NZ-$24.6015.24%
2018NZ-$21.35-2.78%
2017NZ-$21.966.93%
2016NZ-$20.53134.88%
2015NZ-$8.74-29.51%
2014NZ-$12.40-57.34%
2013NZ-$29.07146.55%
2012NZ-$11.7920.83%
2011NZ-$9.76-29.41%
2010NZ-$13.83-48.48%
2009NZ-$26.8410%
2008NZ-$24.4011.11%
2007NZ-$21.96-41.3%
2006NZ-$37.41-66.91%
2005NZ-$113.04110.61%
2004NZ-$53.68-61.63%
2003NZ-$139.88186.67%
2002NZ-$48.80
2001N/A-100%
2000NZ-$39.04-63.64%
1999NZ-$107.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.87-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.47-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.05-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.38-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.38-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$2.12-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA